Cibc Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Cibc Asset Management Inc

  • $26.7 Billion
  • Q1 2024

A detailed history of Cibc Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 31,505 shares of REGN stock, worth $32.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
31,505
Previous 29,813 5.68%
Holding current value
$32.9 Million
Previous $26.2 Million 15.81%
% of portfolio
0.11%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
BUY
$902.69 - $993.35 $1.53 Million - $1.68 Million
1,692 Added 5.68%
31,505 $30.3 Million
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $110,075 - $125,201
142 Added 0.48%
29,813 $26.2 Million
Q3 2023

Oct 30, 2023
BUY
$692.45 - $844.37 $1.95 Million - $2.37 Million
2,809 Added 10.46%
29,671 $24.4 Million
Q2 2023

Aug 14, 2023
SELL
$700.03 - $830.35 $103,604 - $122,891
-148 Reduced 0.55%
26,862 $19.3 Million
Q1 2023

May 12, 2023
BUY
$680.49 - $826.97 $228,644 - $277,861
336 Added 1.26%
27,010 $22.2 Million
Q4 2022

Feb 13, 2023
SELL
$705.89 - $766.39 $7,764 - $8,430
-11 Reduced 0.04%
26,674 $19.2 Million
Q3 2022

Nov 03, 2022
BUY
$573.97 - $724.32 $924,665 - $1.17 Million
1,611 Added 6.42%
26,685 $18.4 Million
Q2 2022

Aug 09, 2022
SELL
$548.35 - $738.84 $140,377 - $189,143
-256 Reduced 1.01%
25,074 $14.8 Million
Q1 2022

May 06, 2022
SELL
$595.12 - $698.43 $444,554 - $521,727
-747 Reduced 2.86%
25,330 $17.7 Million
Q4 2021

Feb 08, 2022
BUY
$543.48 - $670.97 $1.11 Million - $1.37 Million
2,046 Added 8.51%
26,077 $16.5 Million
Q3 2021

Nov 09, 2021
BUY
$574.03 - $680.96 $89,548 - $106,229
156 Added 0.65%
24,031 $14.5 Million
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $610,857 - $721,633
1,292 Added 5.72%
23,875 $13.3 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $1.36 Million - $1.67 Million
3,049 Added 15.61%
22,583 $10.7 Million
Q4 2020

Feb 03, 2021
BUY
$478.3 - $607.98 $610,789 - $776,390
1,277 Added 6.99%
19,534 $9.44 Million
Q3 2020

Nov 05, 2020
BUY
$544.75 - $658.21 $1.58 Million - $1.9 Million
2,892 Added 18.82%
18,257 $10.2 Million
Q2 2020

Jul 28, 2020
BUY
$493.32 - $643.92 $519,959 - $678,691
1,054 Added 7.36%
15,365 $9.58 Million
Q1 2020

Apr 30, 2020
BUY
$336.18 - $494.43 $8,068 - $11,866
24 Added 0.17%
14,311 $6.99 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $202,033 - $277,487
737 Added 5.44%
14,287 $5.36 Million
Q3 2019

Oct 30, 2019
SELL
$273.46 - $318.39 $44,847 - $52,215
-164 Reduced 1.2%
13,550 $3.76 Million
Q2 2019

Aug 05, 2019
BUY
$299.6 - $414.82 $110,552 - $153,068
369 Added 2.77%
13,714 $4.29 Million
Q1 2019

May 06, 2019
SELL
$372.08 - $439.57 $30,882 - $36,484
-83 Reduced 0.62%
13,345 $5.48 Million
Q4 2018

Feb 12, 2019
BUY
$335.82 - $403.04 $91,343 - $109,626
272 Added 2.07%
13,428 $5.02 Million
Q3 2018

Nov 02, 2018
BUY
$351.14 - $408.51 $93,403 - $108,663
266 Added 2.06%
13,156 $5.32 Million
Q2 2018

Aug 09, 2018
BUY
$284.6 - $344.99 $172,183 - $208,718
605 Added 4.92%
12,890 $4.45 Million
Q1 2018

Apr 30, 2018
SELL
$315.82 - $393.78 $10,422 - $12,994
-33 Reduced 0.27%
12,285 $4.23 Million
Q4 2017

Feb 02, 2018
BUY
$358.63 - $469.95 $227,371 - $297,948
634 Added 5.43%
12,318 $4.63 Million
Q3 2017

Nov 06, 2017
BUY
$431.38 - $504.0 $5.04 Million - $5.89 Million
11,684
11,684 $5.22 Million

Others Institutions Holding REGN

# of Institutions
1,426
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email